Katharina Maisel

Dr. Maisel joined the University of Maryland in January 2019. Her interdisciplinary training combines nanotechnology, mucosal immunology, lymphatic immunology, and immunoengineering. The Maisel Lab uses in vitro modeling, nanotechnology, and immunoengineering approaches to study and develop treatments for diseases at mucosal surfaces. We are particularly interested in studying the lymphatics' and interstitial tissue's roles in disease pathology at mucosal surfaces and how the stromal compartment can be targeted for novel treatment strategies. This work creates not only crucial fundamental knowledge about stromal cell involvement in disease pathology, but also leads to novel targets and design criteria for therapeutics.